Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Holland

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2018
Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CTAli Afshar-Oromieh, Lars Peter Sattler, Katja Steiger, et al.
Plos Genetics|October 28, 2024
STIL overexpression shortens lifespan and reduces tumor formation in miceAmira-Talaat Moussa, Marco R Cosenza, Timothy Wohlfromm, et al.
Neuro-Oncology|January 19, 2017
Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM scoreAnna S Berghoff, Fabian Wolpert, Tim Holland-Letz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2015
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with IpilimumabChristoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 8, 2018
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancerAli Afshar-Oromieh, Nils Debus, Monika Uhrig, et al.
Cancers|April 30, 2021
Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort StudyFlorian Seydel, Susanne Delecluse, Martin Zeier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Christian M Zechmann, Anna Malcher, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|November 28, 2015
Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancerPaul Flechsig, Peter Choyke, Clemens Kratochwil, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2019
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic ManagementStefan A Koerber, Gerald Stach, Clemens Kratochwil, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
European Journal of Nuclear Medicine and Molecular Imaging|March 3, 2018
Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CTAli Afshar-Oromieh, Lars Peter Sattler, Katja Steiger, et al.
Plos Genetics|October 28, 2024
STIL overexpression shortens lifespan and reduces tumor formation in miceAmira-Talaat Moussa, Marco R Cosenza, Timothy Wohlfromm, et al.
Neuro-Oncology|January 19, 2017
Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases-development and validation of the LabBM scoreAnna S Berghoff, Fabian Wolpert, Tim Holland-Letz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2015
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with IpilimumabChristoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 8, 2018
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancerAli Afshar-Oromieh, Nils Debus, Monika Uhrig, et al.
Cancers|April 30, 2021
Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort StudyFlorian Seydel, Susanne Delecluse, Martin Zeier, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 28, 2013
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancerAli Afshar-Oromieh, Christian M Zechmann, Anna Malcher, et al.
Diagnostic and Interventional Radiology (Ankara, Turkey)|November 28, 2015
Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancerPaul Flechsig, Peter Choyke, Clemens Kratochwil, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2019
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification taskTitus J Brinker, Achim Hekler, Alexander H Enk, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 2019
Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic ManagementStefan A Koerber, Gerald Stach, Clemens Kratochwil, et al.
Pageof 14